A compound of the formula: wherein R 1 is a phenyl group; R 2 is hydrogen atom or straight or branched C 1 -C 6 alkyl; R 3 is an aryl group; R 4 is hydrogen atom; R 5 and R 7 are each independently hydrogen or halogen atom; R 6 is hydrogen, halogen atom or C 1 -C 6 alkyl group; wherein the groups aryl are carbocyclic or heterocyclic groups containing from 1 to 2 ring moieties, either fused or linked to each other by single bonds, wherein at least one of the rings is aromatic; if present, any aromatic heterocyclic ring also referred to as heteroaryl group, comprises a 5 to 6 membered ring containing from 1 to 3 heteroatoms selected among N, NH, O or S; and wherein the groups aryl, phenyl and straight or branched C 1 -C 6 alkyl may be optionally substituted in any of their free positions, by one or more groups independently selected from: halogen atom, nitro, oxo groups (=O), cyano, C 1 -C 6 alkyl, polyfluorinated alkyl, polyfluorinated alkoxy, alkenyl, alkynyl, hydroxyalkyl, aryl, arylalkyl, heterocyclyl, C 3 -C 6 cycloalkyl, hydroxy, alkoxy, aryloxy, heterocyclyloxy, methylenedioxy, alkylcarbonyloxy, arylcarbonyloxy, cycloalkenyloxy, heterocyclylcarbonyloxy, alkylideneaminooxy, carboxy, alkoxycarbonyl, aryloxycarbonyl, cycloalkyloxycarbonyl, heterocyclyloxycarbonyl, amino, ureido, alkylamino, dialkylamino, arylamino, diarylamino, heterocyclylamino, formylamino, alkylcarbonylamino, arylcarbonylamino, heterocyclylcarbonylamino, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, arylaminocarbonyl, heterocyclylaminocarbonyl, alkoxycarbonylamino, hydroxyaminocarbonyl alkoxyimino, alkylsulfonylamino, arylsulfonylamino, heterocyclylsulfonylamino, formyl, alkylcarbonyl, arylcarbonyl, cycloalkylcarbonyl, heterocyclylcarbonyl, alkylsulfonyl, arylsulfonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, heterocyclylaminosulfonyl, arylthio, alkylthio, phosphonate and alkylphosphonate; provided that the compound 1-methyl-5-{2-[4-(1-methyl-piperidin-4-ylcarbamoyl)-2-trifluoromethoxy-phenylamino]-pyrimidin-4-yl}-1H-pyrrole-3-carboxylic acid o-tolylamide is excluded; and stereoisomers, tautomers, hydrates, solvates, N-oxides and pharmaceutically acceptable salts thereof. R 1 is a phenyl group; R 2 is hydrogen atom or straight or branched C 1 -C 6 alkyl; R 3 is an aryl group; R 4 is hydrogen atom; R 5 and R 7 are each independently hydrogen or halogen atom; R 6 is hydrogen, halogen atom or C 1 -C 6 alkyl group; wherein the groups aryl are carbocyclic or heterocyclic groups containing from 1 to 2 ring moieties, either fused or linked to each other by single bonds, wherein at least one of the rings is aromatic; if present, any aromatic heterocyclic ring also referred to as heteroaryl group, comprises a 5 to 6 membered ring containing from 1 to 3 heteroatoms selected among N, NH, O or S; and wherein the groups aryl, phenyl and straight or branched C 1 -C 6 alkyl may be optionally substituted in any of their free positions, by one or more groups independently selected from: halogen atom, nitro, oxo groups (=O), cyano, C 1 -C 6 alkyl, polyfluorinated alkyl, polyfluorinated alkoxy, alkenyl, alkynyl, hydroxyalkyl, aryl, arylalkyl, heterocyclyl, C 3 -C 6 cycloalkyl, hydroxy, alkoxy, aryloxy, heterocyclyloxy, methylenedioxy, alkylcarbonyloxy, arylcarbonyloxy, cycloalkenyloxy, heterocyclylcarbonyloxy, alkylideneaminooxy, carboxy, alkoxycarbonyl, aryloxycarbonyl, cycloalkyloxycarbonyl, heterocyclyloxycarbonyl, amino, ureido, alkylamino, dialkylamino, arylamino, diarylamino, heterocyclylamino, formylamino, alkylcarbonylamino, arylcarbonylamino, heterocyclylcarbonylamino, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, arylaminocarbonyl, heterocyclylaminocarbonyl, alkoxycarbonylamino, hydroxyaminocarbonyl alkoxyimino, alkylsulfonylamino, arylsulfonylamino, heterocyclylsulfonylamino, formyl, alkylcarbonyl, arylcarbonyl, cycloalkylcarbonyl, heterocyclylcarbonyl, alkylsulfonyl, arylsulfonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, heterocyclylaminosulfonyl, arylthio, alkylthio, phosphonate and alkylphosphonate; provided that the compound 1-methyl-5-{2-[4-(1-methyl-piperidin-4-ylcarbamoyl)-2-trifluoromethoxy-phenylamino]-pyrimidin-4-yl}-1H-pyrrole-3-carboxylic acid o-tolylamide is excluded; and stereoisomers, tautomers, hydrates, solvates, N-oxides and pharmaceutically acceptable salts thereof.